AiCure

Articles Published in 2012

BBK Worldwide announces two hires to client services dept

Thursday, December 6, 2012 02:57 PM

BBK Worldwide, the recognized global leader in patient recruitment, recently hired Rebecca Panzer and Lindsay Court to the company’s client services department. Panzer and Court will contribute their knowledge and expertise in managing day-to-day client team activities.

More... »


Roche, IMI launch StemBANCC partnership for stem cells as research tools

Wednesday, December 5, 2012 02:03 PM

Switzerland-based Roche and the Innovative Medicines Initiative (IMI), Europe's largest public-private initiative aiming to speed up the development of better and safer medicines for patients, have launched StemBANCC, a new academic–industry partnership that unites 10 pharmaceutical companies and 23 academic institutions.

More... »


INC Research launches strategic advisory services unit

Wednesday, December 5, 2012 12:02 PM

INC Research, a therapeutically focused CRO, has launched INC Research Strategic Advisory Services, a new global business unit dedicated to providing biopharmaceutical customers with world-class consulting capabilities in the areas of drug development and commercialization, regulatory consulting and submissions and quality assurance.

More... »

UAE, Merck Serono, Neopharma form first pharmaceutical production agreement

Wednesday, December 5, 2012 11:35 AM

Merck Serono, a division of Germany-based Merck, and a local manufacturer, Neopharma, have formed the first partnership of its kind to locally produce Merck branded medication in the UAE for distribution across the Middle East.

More... »

Geron discontinues GRN100, cuts 43 workers

Wednesday, December 5, 2012 11:08 AM

Geron, a Menlo Park, Calif.-based biopharmaceutical company developing first-in-class therapies for cancer, has discontinued development of GRN1005, its peptide-drug conjugate designed to treat cancers in the brain. Going forward, the company will focus on the development of imetelstat, its telomerase inhibitor, in hematologic myeloid malignancies and in patients with solid tumors that have short telomeres.

More... »

AAIPharma appoints Browne as director of analytical chemistry

Wednesday, December 5, 2012 11:02 AM

AAIPharma Services, a provider of pharmaceutical product development services, has appointed David Browne as the company's director of analytical chemistry for its Edison, N.J., laboratory.

More... »

Baxter to acquire Gambro, enhance renal therapies portfolio

Wednesday, December 5, 2012 10:40 AM

Baxter International, a global healthcare company, has entered into a definitive agreement to acquire Gambro, a privately held dialysis product company based in Lund, Sweden, for total consideration of approximately $4 billion.

More... »

Emmaus Medical completes enrollment for phase III sickle cell disease trial

Wednesday, December 5, 2012 10:11 AM

Emmaus Medical, a specialty pharmaceutical and regenerative medicine company, has completed patient enrollment for its phase III clinical trial to study L-glutamine as a treatment for sickle cell disease.

More... »

ALS TDI, Gladstone Institutes to discover potential ALS treatments

Wednesday, December 5, 2012 09:44 AM

The ALS Therapy Development Institute (ALS TDI), aimed at developing effective therapeutics that slow or stop amyotrophic lateral sclerosis (ALS), and the Gladstone Institutes, a nonprofit biomedical-research organization, have formed a research collaboration to speed the discovery of potential treatments for ALS through the preclinical drug development process.

More... »

Covance receives SFDA GLP certification for early development facility

Wednesday, December 5, 2012 09:16 AM

Covance, a drug development services company, announced that its early development facility located in Shanghai, China, has received a Good Laboratory Practice (GLP) certificate from the State Food and Drug Administration (SFDA) of the People’s Republic of China.

More... »

`
CenterWatch Data Library
CLINICAL TRIAL RESOURCES

Search:

NEWS ONLINE ARCHIVE

Browse by:

CWWeekly

November 24

Tufts CSDD’s $2.6 billion price tag to develop and bring a new drug to market raises questions, criticisms

Medidata joins GlaxoSmithKline in study to evaluate the impact of wearing mobile devices in clinical trials

Already a subscriber?
Log in to your digital subscription.

Subscribe to CWWeekly.

The CenterWatch Monthly

November

Private equity driving dynamic CRO growth
Enables CROs to pursue long-term strategies, while giving the space credibility

Baby boomers poised to reshape clinical trials industry
Millions of tech-savvy consumers already track their health, expect new treatments as they age

Already a subscriber?
Log in to your digital subscription.

Purchase the September issue.

Subscribe to
The CenterWatch Monthly.

The CenterWatch Monthly

October

CROs driving changes in patient recruitment
Data- and tech-aided enrollment services a competitive advantage

Trials with in-home nurses poised to grow
Higher expense, but may improve recruitment and retention for select trials

Already a subscriber?
Log in to your digital subscription.

Purchase the October issue.

Subscribe to
The CenterWatch Monthly.

JobWatch centerwatch.com/jobwatch

Featured Jobs